Skip to main content

Table 2 The clinicopathology features and survival distribution of small cell GBM patients

From: A prognostic analysis of pediatrics central nervous system small cell tumors: evaluation of EGFR family gene amplification and overexpression

GBM

Number of patients

Median survival times

P value

19 cases

(Cases were dead)

X ± s(months)

(<0.05)

Sex

  

0.365

Male

13(10)

8 ± 4.676

 

Female

6(4)

10 ± 0.031

 

Resection stage

  

0.0744

Total resection

11(8)

10 ± 1.309

 

Partial resection

8(6)

4 ± 3.771

 

Therapy

  

0.00031

Surgery only

12(10)

3 ± 0.476

 

Surgery + Radiotherapy

7(4)

11 ± 1.095

 

Ki67

  

0.0359

0,1+

9(6)

10 ± 2.449

 

2+, 3+

6(4)

4 ± 0.376

 

EGFR (IHC) (15 cases)

  

0.0085

0,1+, 2+

7(5)

11 ± 1.138

 

3+

8(5)

3 ± 1.194

 

EGFR (FISH) (15 cases)

  

0.0267

Negative

8(5)

11 ± 1.646

 

Positive

7(5)

3 ± 1.047